Contact Us

ReNu Contact Solution
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker & Waichman, LLP Retained by More Than 30 Users of ReNu MultiPlus Solution who Suffered Significant Eye Injuries, Over 1/3 Required or will Require Cornea Transplant Surgery

Firm Calls on Bausch & Lomb, Inc. to Suspend Sales of ReNu MultiPlus Solution

May 9, 2006 |

Parker & Waichman, LLP ( announced that it has been retained by more than 30 consumers who suffered significant eye injuries after having used ReNu MultiPlus Multi-Purpose Solution. More than 10 of these retained clients either have undergone or will require corneal transplant surgery. ReNu with MoistureLoc and ReNu MultiPlus are manufactured by Bausch & Lomb, Inc. (NYSE: BOL). For more information on fungal infections associated with ReNu products please visit: or

In an update issued today by the CDC concerning its ongoing Fusarium Keratitis investigation, the agency indicated that ReNu MultiPlus was used in 21% of confirmed Fusarium cases. With the release of the CDC data, Parker & Waichman, LLP believes that Renu MultiPlus poses a health hazard to consumers similar to that posed by ReNu with MositureLoc, and calls upon Bausch & Lomb, Inc. to immediately recall all ReNu products from the market. “This is a public health hazard that is escalating, “commented Jerrold Parker, founding partner of Parker & Waichman, LLP. “Until further information is available to substantiate the safety of Bausch & Lomb’s ReNu contact lens solutions, the only prudent course is to recall the products to prevent additional infections.”

On April 13, 2006, Bausch & Lomb, Inc. advised consumers to switch to another lens care solution and asked all retailers to remove ReNu with MoistureLoc from their shelves. This action came after the FDA and the CDC issued public health warnings on April 10, 2006 concerning serious fungal infections associated with contact lens solution use. Today, the CDC issued an update on its investigation into Fusarium Keratitis, revealing that ReNu products were used in 97 percent of the confirmed cases of infection. Among confirmed Fusarium patients, 66% used ReNu with MositureLoc, 21% used ReNu MultiPlus, and 10% used an unspecified ReNu product. To date, Bausch & Lomb, Inc. has not asked consumers to stop using ReNu MultiPlus solution, and the product remains available in stores nationwide.

Fusarium keratitis is a severe infection of the cornea. Risk factors for infection usually include trauma (generally with plant material), chronic ocular surface diseases, immunodeficiencies, and, rarely, contact lens use. An estimated 30 million persons in the United States wear soft contact lenses; the annual incidence of microbial keratitis is estimated to be 4-21 per 10,000 soft contact lens users. Fusarium keratitis is more prevalent in warm climates. First-line treatment includes topical and oral antifungal medications; patients who do not respond to these treatments usually require surgical intervention, including corneal transplantation. These fungal infections are not transmitted from person to person.

About Parker & Waichman, LLP

Parker & Waichman, LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide. The firm has offices in New York and New Jersey. Parker & Waichman, LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective medications and medical devices. Parker & Waichman, LLP has been retained by more than 200 individuals who suffered serious eye injuries after using a ReNu product and currently has cases pending in state and federal courts. Parker & Waichman, LLP was the first law firm nationwide to file a class action on behalf of victims of ReNu with MoistureLoc. The class action seeks, among other remedies, a medical monitoring fund to enable consumers to obtain medical screening and treatment services. Parker & Waichman, LLP has successfully represented victims of Ortho Evra, Vioxx, Zyprexa, Bextra, Guidant Defibrillators and Medtronic Pacemakers. For more information on Parker & Waichman, LLP please visit: ( or call 1-800-YOURLAWYER (1-800-968-7529).

CONTACT: Parker & Waichman, LLP

Jason Mark, Esq.

Melanie H. Muhlstock, Esq.


1-800-968-7529 -- toll-free

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo